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Objective: We aimed to evaluate the effects of resistance exercise (RE) and leucine (LEU) supple-
mentation on dexamethasone (DEXA)-induced muscle atrophy and insulin resistance.
Methods: MaleWistar ratswere randomlydivided intoDEXA (DEX), DEXAþRE (DEX-RE),DEXAþ LEU
(DEX-LEU), and DEXAþ REþ LEU (DEX-RE-LEU) groups. Each group received DEXA 5mg $ kg1 $ d1
for 7 d from drinking water and were pair-fed to the DEX group; LEU-supplemented groups received
0.135 g $ kg1 $ d1 through gavage for 7 d; the RE protocol was based on three sessions of squat-type
exercise composed by three sets of 10 repetitions at 70% of maximal voluntary strength capacity.
Results: The plantaris mass was signiﬁcantly greater in both trained groups compared with the
non-trained groups. Muscle cross-sectional area and ﬁber areas did not differ between groups.
Both trained groups displayed signiﬁcant increases in the number of intermediated ﬁbers (IIa/IIx),
a decreased number of fast-twitch ﬁbers (IIb), an increased ratio of the proteins phosphoSer2448/
total mammalian target of rapamycin and phosphoThr389/total 70-kDa ribosomal protein S6 kinase,
and a decreased ratio of phosphoSer253/total Forkhead box protein-3a. Plasma glucose was signif-
icantly increased in the DEX-LEU group compared with the DEX group and RE signiﬁcantly
decreased hyperglycemia. The DEX-LEU group displayed decreased glucose transporter-4 trans-
location compared with the DEX group and RE restored this response. LEU supplementation
worsened insulin sensitivity and did not attenuate muscle wasting in rats treated with DEXA.
Conversely, RE modulated glucose homeostasis and ﬁber type transition in the plantaris muscle.
Conclusion: Resistance exercise but not LEU supplementation promoted ﬁber type transition and
improved glucose homeostasis in DEXA-treated rats.
 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction Several studies have demonstrated its therapeutic role in im-Leucine (Leu) supplementation has been a constant focus of
investigation of skeletal muscle disorders characterized bymuscle
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lsevier OA license.proving muscle nitrogen balance under experimental conditions
such as muscle immobilization [3], aging [4–6], and sepsis [7].
Some reports have also showed that, as an insulin secretagogue,
Leu has a potential role in modulating glucose homeostasis [8,9].
Thus, Leu has emerged as an interesting nutritional strategy for
treating conditions characterized by skeletal muscle atrophy and
disturbance in glucose metabolism.
Similarly, resistance exercise (RE) has been described as one
of the strongest and most effective non-pharmacologic treat-
ments against skeletal muscle atrophy [10,11]. In animal models,
H. Nicastro et al. / Nutrition 28 (2012) 465–471466despite the limitations of the RE models and protocols, some
studies have also observed attenuation of muscle atrophy under
catabolic conditions such as muscle disuse [12–16]. Furthermore,
we recently demonstrated in a case report that chronic RE with
vascular occlusion attenuated the loss of skeletal muscle func-
tionality (strength) in a subject with body inclusionmyositis [17].
RE also promotes the therapeutic role of glucose homeostasis,
because mechanical stimuli are widely known to improve
glucose uptake to skeletal muscle through glucose transporter-4
(GLUT4) translocation to the sarcolemma [18]. In this context,
our group observed that type 2 diabetic subjects who submitted
to chronic exercise improved glycemic control most likely by
enhancing the GLUT4 translocation [19]. In view of these ﬁnd-
ings, RE may also be considered an effective therapy to coun-
teract simultaneously muscle wasting and insulin resistance.
Conversely, despite their wide therapeutic actions [20],
glucocorticoids used in high doses or chronically for longer
periods can induce several side effects that may include, among
others, diabetes mellitus [21,22] and selective skeletal muscle
atrophy [23–26] of fast-twitch ﬁbers [27]. It has been described
that steroidal glucocorticoids can stimulate the translocation of
speciﬁc transcription factors to the nucleus thatmay enhance the
transcription of genes involved in skeletal muscle loss [26]. This
effect can bemodulated directly, through glucocorticoid receptor
translocation, and/or indirectly by the impairment of signaling
pathways that are responsive to insulin [28]. The potential role of
Leu supplementation and RE in counteracting such effects and
the possible mechanisms underlying these responses are not
totally elucidated.
Therefore, the aim of the present study was to investigate the
effects of Leu supplementation and RE on the skeletal muscle
atrophy and glucose homeostasis of rats treated with a high dose
of dexamethasone (DEXA). Furthermore, we evaluated the
possible molecular mechanisms involved in muscle wasting and
glycemic control. Our main hypothesis was that RE exercise
could attenuate muscle atrophy and improve glucose homeo-
stasis in this model and that Leu supplementation would exert
positive synergic effects through the stimulation of protein
synthesis initiation and glucose uptake.
Materials and methods
Animals
The experiments were conducted in accordance with the National Research
Council’s Guidelines for the Care and Use of Laboratory Animals. All methods
usedwere approved by the ethical committee for animal research of the School of
Physical Education and Sports, University of Sao Paulo. Adult male Wistar rats
(w400 g) were housed under controlled environmental conditions (temperature
22C, 12-h dark period). They were given free access to commercial laboratory
chowandwater before the experiments were performed. Twenty-three ratswere
randomly divided into the following groups: DEXA (DEX; n ¼ 06), DEXA þ RE
(DEX-RE; n¼ 05), DEXAþ Leu (DEX-LEU; n¼ 07), and DEXAþ REþ Leu (DEX-RE-
LEU; n ¼ 05). DEXA (a synthetic glucocorticoid analog that does not bind
to plasma-binding proteins) was replaced fresh every morning at 09:00 h
with the drinking water. Each group received DEXA 5 mg $ kg1 $ d1 for 7 d
with the drinking water; DEXA concentrations were adjusted every day based on
the intake of drinking water the day before. This protocol was chosen based
on our previous study demonstrating that this DEXA dosage can promote
signiﬁcant plantaris muscle atrophy compared with healthy animals [28].
Leu-supplemented groups received 0.135 g $ kg1 $ d1 through gavage [29] for 7
d. Because DEXA has been reported to decrease food intake, all groups were pair-
fed to the DEX group. Thus, differences among groups do not originate from
different food intakes. Animals were euthanized by decapitation 48 h after the
last RE session and a 12-h fast. The plantaris muscles of each limb were isolated,
weighed, and frozen at 80C for protein expression analysis. For the GLUT4
translocation experiments, we repeated the experimental protocols and animals
had free access to food and water and then were euthanized in the basal state
(not fasted; n ¼ 4 per group).RE protocol
Resistance exercise was based on the model of Wirth et al. [30]. Brieﬂy, rats
performed three sessions of a squat-type exercise in one daily session, with a rest
interval of 2 d between sessions. In each session, the rats performed 30 repeti-
tions (3 sets of 10 repetitions) composed of concentric forces [30], which lasted
approximately 20 min. The minimum height for collar lifting was ﬁxed at 3.0 cm
becausewe observed that in our training apparatus this was theminimum height
required for the animals to perform a full plantar ﬂexion. The rest interval
between repetitions was about 10 to 20 s, and the load lifted in each session was
70% of the maximal voluntary strength capacity (MVSC). The eighth repetition
test was used to assess the MVSC of each rat and was previously standardized by
our group [31–33]. If the rat was successful, the load was increased by 2% until
failure. When a lift was not properly performed, the load was decreased by 2% in
relation to the MVSC. The load of 70% MVSC was chosen not only because it is
within the range of load capable of inducing hypertrophy in human studies [34]
but also because it was observed that the rats proved unable to lift the near
maximal/maximal loads (>95%MVSC). To obtain the initial MVSC value, the total
mass of weights on the lever was gradually increased until the rats proved unable
to lift the lever. Therefore, the loads were always lifted in an individualized
manner and adjusted according to the MVSC.
Muscle dry/wet ratio
Muscle tissues were desiccated for 5 d in a drying oven set at 50C before
determination of the dry weight. The dry/wet weight ratio was determined as
previously described [35].
Histologic analysis
The collected plantaris muscles were also embedded in tissue tek, cooled in
isopentane, frozen in liquid nitrogen, and sectioned with a cryostat. The resulting
10-mm transverse sections were examined with adenosine triphosphatase
staining (pH 4.6). To decrease the inﬂuence of anatomic area on the ﬁber type
distribution, all plantaris muscles were sectioned in the belly after removal.
Fibers without horizontal orientation and/or damaged owing to the section
process were not considered for analysis. Cross-sectional areas (CSAs) of 450
muscle ﬁbers of a muscle from each rat were measured using Image Pro-Plus
(Media Cybernetics, Bethesda, MD, USA) software.
Plasma insulin and glucose levels
Bloodwas collected and serum samples were separated after allowing blood to
clot on ice. Serum was stored at 80C for further analysis. Plasma insulin was
measured using commercial radioimmunoassay kits (DPC Medlab, S~ao Paulo, SP,
Brazil). Plasma glucose levels were measured using an automatizedmethod (Accu-
Chek Active System, Roche Diagnostics, Mannheim, Germany). The homeostasis
model for assessment of insulin resistance (HOMA-IR) index was calculated as
follows: HOMA-IR index (mmol $ mU $ L2) ¼ fasting insulin (mU/L)  serum
glucose (mmol/L)/22.5 [36].
Cellular fractionation for GLUT4 protein expression
Muscle samples were minced and homogenized in ice-cold lysis buffer (2
mM ethylenediaminetetraacetic acid, 10 mM ethylene glycol bis[2-aminoetyl
ether]-N,N,N0 ,N0 ,-tetraacetic acid, 0.25 M sucrose, 1:300 Sigma (Sigma-Aldrich,
St. Louis, MO, USA) protease inhibitor cocktail, and 20mM Tris-HCl at pH 7.5). The
homogenate was centrifuged at 100 000  g for 30 min (4C) to obtain the
membrane fraction.
Western blot
Bradford assays were used to determine the sarcoplasmic protein concen-
tration and then samples were standardized to 1 mg/mL by dilution with 3
Laemmli loading buffer. Brieﬂy, samples were subjected to sodium dode-
cylsulfate polyacrylamide gel electrophoresis in 8% polyacrylamide gels. After
electrophoresis, proteins were electrotransferred to a nitrocellulose membrane
through a Transblot Semi Dry Transfer Cell Bio-Rad Laboratories (Hercules, Cal-
ifornia, USA). Equal loading of samples and transfer efﬁciency were monitored
with the use of 0.5% Ponceau S staining of the blot membrane. The blotted
membrane was then blocked with 5% low-fat milk (total) or 5% bovine serum
albumin (for phospho-antibodies) in Tris-buffered saline with Tween (TBS-T) for
1 h, and then membranes were incubated overnight with the following primary
antibodies to evaluate glucose homeostasis and the synthetic and proteolytic
signaling pathways: GLUT4 (1:1000; Millipore, Billerica, MA, USA), total
mammalian target of rapamycin (mTOR), phospho-mTORSer2448, total 70-kDa
ribosomal protein S6 kinase (p70S6k), phospho-p70S6kThr389, total Forkhead
box protein-3a (FoxO3a), phospho-FoxO3aSer253, and muscle-speciﬁc RING
Table 1
Body weight, skeletal muscle weight, blood glucose, and plasma insulin of each experimental group*
Variable Group
DEX (n ¼ 6) DEX-LEU (n ¼ 7) DEX-RE (n ¼ 5) DEX-RE-LEU (n ¼ 5)
Basal BW (g) 409  17.9 414  31.3 396  13.4 416  20.1
Final BW (g) 306  0.9 290  33.5 315  20.1 292  32.6
Plantaris weight (mg) 265  40.2 256  38.3 313  29.1yz 316  35.8yz
Plantaris dry/wet ratio (mg) 0.26  0.04 0.25  0.07 0.25  0.04 0.26  0.04
Plantaris weight/basal BW (mg/g) 0.65  0.09 0.62  0.09 0.79  0.07yz 0.77  0.08yz
Blood glucose (mmol/L) 7.8  1.3x 16.1  2.0yx{ 5.3  0.5 7.6  1.8x
Plasma insulin (mU/L) 47.7  3.3x 65.7  22.4yx{ 25.9  2.9{ 49.5  11.2x
HOMA-IR index (mmol $ mU1 $ L2) 12.7  7.4 47.7  11.0yx{ 6.2  0.2{ 16.8  3.6x
BW, body weight; DEX, dexamethasone; HOMA-IR, homeostasis model for assessment of insulin resistance; LEU, leucine supplementation; RE, resistance exercise
* Values are presented as mean  SD.
y P < 0.05 versus DEX.
z P < 0.05 versus DEX-LEU.
x P < 0.05 versus DEX-RE.
{ P < 0.05 versus DEX-RE-LEU.
H. Nicastro et al. / Nutrition 28 (2012) 465–471 467ﬁnger-1 (MuRF-1; 1:1000; Cell Signalling, Danvers, MA, USA). Membranes were
then washed with TBS-T and incubated for 1 h at room temperature with
a horseradish peroxidase–conjugated anti-rabbit secondary antibody (1:10 000;
Cell Signalling), before further washing with TBS-T and incubation for 1 minwith
enhanced chemiluminescence (ECL). Quantiﬁcation analysis of blots was per-
formed using Image J (National Institute of Health, Bethesda, MD, USA). Protein
expressions were normalized against glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH).Data analysis
The dependent variables were tested by one-way or two-way analysis of
variance. A post hoc test with a Tukey adjustment was performed for multiple
comparison purposes. Student’s t test was used for comparisons between trained
groups. The signiﬁcance level was set at P < 0.05. The results are expressed as
mean  standard deviation.Baseline 1 2 3 4 5 6 7
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Fig. 1. Body weight (A) and food intake (B) progression data among groups. (A)
aP < 0.05 signiﬁcant differences among all groups versus baseline. DEX, dexa-
methasone; LEU, leucine supplementation; RE, resistance exercise.Results
Characterization of RE protocol
All groups underwent the stages of exercise adaptation as
proposed by Wirth et al. [30]. At the end of the apparatus-
adaptation phase, the animals from the DEX-RE and DEX-RE-
LEU groups were subjected to the MVSC test, which did not
differ between these groups (P > 0.05; Supplemental
Figure S1A). Animals from groups DEX and DEX-LEU were sub-
jected to the same period of environmental stress as the animals
from the trained groups. The average length of each exercise
session was 1461  225 and 1370  109 s for the DEX-RE and
DEX-RE-LEU groups, respectively (P > 0.05; Supplemental
Figure S1C). The mean time of each set was also measured and
did not differ among groups (P > 0.05). As observed in Supple-
mental Figure S1B, the length of the ﬁrst set (609  192 and
610  80 s for the DEX-RE and DEX-RE-LEU groups, respectively)
was quite superior compared with the second set (318  47 and
367 70 s for the DEX-RE and DEX-RE-LEU groups, respectively)
and the third set (350  79 and 428  74 s for the DEX-RE and
DEX-RE-LEU groups, respectively). This is explainable because
the exercise sessions were separated by 48 h, and in the ﬁrst set
of each session, the animals recognized the environment before
engaging in the exercise protocol. The height of the collar
displacement did not differ between groups and presented
average values of 3.02  0.74 for the DEX-RE group and 3.44 
0.69 for the DEX-RE-LEU group (P > 0.05; Supplemental
Figure S1D). Concentric strength also did not differ among
groups during the entire experiment (P > 0.05; Supplemental
Figure S2).RE and Leu supplementation did not modulate body weight and
food intake in DEXA-treated animals
As presented in Table 1, both groups started and ﬁnished the
experiment with similar body weights (P > 0.05). Despite body
weight and food intake being signiﬁcantly decreased from the
second to the last day of treatment (P < 0.05; Fig. 1A,B), these
variables did not differ among groups (P > 0.05), demonstrating
that neither RE nor Leu supplementation counteracted the
effects induced by the DEXA treatment. Water intake was not
different among groups (data not shown).
RE, but not Leu supplementation, increased plantaris muscle mass
in DEXA-treated animals
Of all the interventions applied, only RE was able to increase
the plantaris muscle mass in DEXA-treated rats. The DEX-RE and
H. Nicastro et al. / Nutrition 28 (2012) 465–471468DEX-RE-LEU groups presented higher values of plantaris muscle
mass and plantaris mass/basal body weight compared with the
other groups (P < 0.05; Table 1) but without signiﬁcant differ-
ences between them (P > 0.05). Thus, Leu supplementation did
not promote synergistic effects on RE inmodulating the plantaris
muscle mass. The DEX-LEU group did not show any modiﬁcation
in the plantaris mass compared with the DEX group (P > 0.05),
demonstrating that Leu supplementation alone also was not able
to modulate the plantaris muscle mass. The muscle dry/wet ratio
did not differ among groups (P > 0.05).
RE, but not leucine supplementation, did not change plantaris
CSA but modulated ﬁber type proﬁle in DEXA-treated animals
Figure 2 shows the plantaris muscle CSA and ﬁber type proﬁle
of all groups. Leu supplementation (DEX-LEU) did not change any
of these parameters compared with the DEX group (P > 0.05;
Fig. 2). However, in the DEX-RE group, although the plantaris
muscle CSA and ﬁber areas were unaltered compared with the
other groups (P > 0.05; Fig. 2F,G), the number of intermediate
ﬁbers (IIa/IIx) was signiﬁcantly increased and the number of fast-
twitch ﬁbers (IIb) was decreased compared with the DEX and
DEX-LEU groups (P < 0.05; Fig. 2E). The DEX-RE-LEU group did
not show any difference in the plantaris muscle CSA compared
with the other groups (P> 0.05; Fig. 2G) and in similar ﬁber type
phenotype compared with the DEX-RE group (P > 0.05; Fig. 2E).
RE improved glucose homeostasis in DEXA-treated animals
through GLUT4 translocation and Leu supplementation
minimized such responses
Resistance exercise (DEX-RE group) decreased fasting blood
glucose (P < 0.05 versus others) and Leu supplementation (DEX-
LEU group) aggravated it (P < 0.05 versus others) and partly
blunted the therapeutic effect of RE (DEX-RE-LEU group; P< 0.05Fig. 2. Examples of transverse muscle sections with histochemical staining for myosin a
DEX, (B) DEX-LEU, (C) DEX-RE, and (D) DEX-RE-LEU groups. Fiber types I, IIa, IIx, and IIb
area data are presented as mean  SD. aP < 0.05 versus DEX group; bP < 0.05 versus D
exercise.versus others). Plasma insulin and HOMA-IR followed the same
result pattern of blood glucose (DEX-LEU¼DEX-RE-LEU>DEX>
DEX-RE group; P < 0.05; Table 1).
Total GLUT4 protein expression did not differ among groups
(P > 0.05; Fig. 3A). However, RE (DEX-RE group) signiﬁcantly
increased the basal membrane/total GLUT4 ratio (P< 0.05 versus
others; Fig. 3B). Leu supplementation (DEX-LEU group) impaired
the GLUT4 translocation to the cell surface (P < 0.05 versus
others) and partly decreased (DEX-RE-LEU) the effect induced by
RE (P < 0.05 versus others).
DEXA treatment modulated the expression of proteins involved in
muscle remodeling and RE, but not Leu supplementation,
improved such responses
Regarding synthetic machinery, the total protein expression
of mTOR, p70S6k, and FoxO3a did not differ among groups (P >
0.05l; Fig. 3A). However, the DEX-RE and DEX-RE-LEU groups
presented signiﬁcantly increased the phosphoSer2448/total mTOR
ratio (Fig. 3C) and phosphoThr389/total p70S6k ratio (Fig. 3D)
compared with the untrained groups (P < 0.05) but without
differences between them (P > 0.05), suggesting no synergistic
effects of Leu supplementation on RE responses. Leu supple-
mentation (DEX-LEU group) did not modulate the expression of
such protein ratios compared with the DEX group (P> 0.05). The
phosphoSer253/total FoxO3a ratio (Fig. 3E) was similarly
decreased in both trained groups compared with the untrained
groups (P< 0.05). MuRF-1 did not differ between the trained and
untrained groups (P > 0.05; Fig. 3F).
Leu supplementation attenuates performance in RE-trained and
DEXA-treated rats
Because the animals were euthanized 48 h after the last
exercise session, we were unable to perform an MVSC test at thedenosine triphosphatase, preincubated at pH 4.6 in plantaris muscles from the (A)
were identiﬁed. (E) Fiber type proﬁle, (F) ﬁber area, and (G) muscle cross-sectional
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H. Nicastro et al. / Nutrition 28 (2012) 465–471 469end of the experiment because it can induce severe alterations in
the phosphorylation status of several proteins. Therefore, we
considered the concentric strength of the last session as a func-
tional parameter. Although the concentric strength of the entire
experiment did not differ between trained groups (P > 0.05;
Supplemental Figure S1A), this variable was signiﬁcantly altered
in the last exercise session. As shown in Figure 4, the DEX-RE
group presented higher concentric strength compared with the
DEX-RE-LEU group (P < 0.05).
Discussion
To our knowledge, this is the ﬁrst study that investigated the
effects of RE combined with Leu supplementation on skeletal
muscle remodeling and glucose homeostasis in a DEXA treat-
ment experimental model. The major ﬁndings of the present
study were that RE positively modulated the skeletal muscle
phenotype and improved glucose homeostasis in DEXA-treated
animals. Such an effect can be partly explained by the phos-
phorylation of proteins involved in the synthetic (mTOR andp70S6k phospho/total ratio) and proteolytic (FoxO3a phospho/
total ratio) machinery and glucose uptake (GLUT4 translocation
to the sarcolemma) in skeletal muscle. In contrast, Leu supple-
mentation did not promote any therapeutic effect and worsened
glucose homeostasis, as evidenced by the metabolic (insulin
sensitivity), molecular (GLUT4 translocation), and functional
(concentric strength) data.
Exercise training has been considered a key complementary
tool in many different health conditions, mainly aimed at
performance. However, more recently, RE also has been used as
a therapeutic tool to treat several different diseases to prevent
the loss of muscle mass and to improve the metabolic proﬁle of
the whole body or speciﬁc tissues [37], as in the case of pro-
longed and high-dose DEXA treatment. In the present study, we
demonstrated that even three sessions of high-intensity RE (70%
MVSC with intervals of w10 s between repetitions and w90 s
between series) were capable of drastically decreasing the
consequences of high-dose DEXA treatment in the RE-trained
group, improving the metabolic proﬁle linked with impaired
glucose homeostasis (as evidenced by decreased fasting plasma
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Fig. 4. Leucine supplementation attenuates RE performance in RE-trained and
DEX-treated rats. Boxplot visualizes the concentric strength of the last exercise
session. aP < 0.05 versus DEX-RE-LEU group. DEX, dexamethasone; LEU, leucine
supplementation; RE, resistance exercise.
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pathway of glucose, such as basal GLUT4 translocation to the cell
sarcolemma [18,38,39].
In a previous study by our group, the present protocol of
DEXA demonstrated the promotion of signiﬁcant plantaris
muscle wasting and insulin resistance compared with healthy
animals [28]. Although the weight of the plantaris muscle was
increased in the RE-trained groups compared with the untrained
groups, this datumwas not reproduced in the histologic analysis,
which was probably due to the variability in the dissection of the
tendon and connective tissues spared by RE. Thus, three RE
sessions were not capable of preventing the DEXA-induced
muscle atrophy but increased the phosphorylation of mTOR
and p70S6k in key residueamount that contribute to protein
synthesis [40–43]. Such a biological response reﬂects the
residual effect of RE because the groups were euthanized 48 h
after the last training session. Thus, it is possible to speculate that
RE executed during a more prolonged period, even in the pres-
ence of high doses of DEXA, could signiﬁcantly attenuate plan-
taris muscle loss. Conversely, changes in the phenotype of
muscle ﬁbers occurred, and this is a condition that could improve
the molecular muscle engine and potentially lead to increases in
the strength and power of the muscle ﬁber [41]. In fact, as ex-
pected, there was a transition from type IIb to type IIa/IIx muscle
ﬁbers in the RE-trained animals compared with the untrained
animals. Such a change might represent a beneﬁcial physiologic
effect that was not blocked by DEXA treatment alone, as previ-
ously demonstrated [44].
Leucine supplementation has been considered a nutritional
non-pharmacologic approach in aging [4–6,45–47]. However,
the effect of very high doses of DEXA combined with RE and Leu
supplementation (in a dose that is known to be capable of
increasing skeletal muscle protein synthesis in healthy condi-
tions) [29] has not yet been demonstrated. Based on these
previous experiments, we expected that Leu supplementation
combined RE would be capable of promoting the synergistic
effects on RE in preventing skeletal muscle atrophy and
improving glucose homeostasis. However, we observed that Leu
supplementation did not promote any beneﬁts for muscle
remodeling and worsened glucose homeostasis compared withthe other groups, as demonstrated by insulin sensitivity, fasting
blood glucose, and the HOMA-IR index and the molecular data of
basal GLUT4 translocation to the cell surface. These data
corroborate with the literature [5]. Leu supplementation per se
interacted with DEXA treatment in worsening glucose homeo-
stasis, an effect that was not dependent on muscle mass.
Recently, Leu supplementation has been demonstrated to induce
a delay in the insulin signaling pathway (IR/PI3K protein
expression) in skeletal muscle [48]. Thus, the conclusion that was
considered for Leu supplementation is that it does not promote
synergistic effects on RE in muscle remodeling, induces a signif-
icant degree of insulin resistance in skeletal muscle, and atten-
uates the therapeutic effect of RE on glucose homeostasis under
DEXA treatment (e.g., similar muscle mass, mTOR and p70S6K
phospho/total ratio, FoxO3a transcription factor phospho/total
ratio, and decreased basal GLUT4 translocation to the sarco-
lemma). For protein synthesis, we assumed that the Leu effects
could be more visible in the postprandial state instead of the
postabsorptive state. However, this was not the case for the basal
GLUT4 translocation because the animals were not in a fasted
state.
In summary, our results are conclusive that RE, even in the
presence of high doses of DEXA, improves glucose homeostasis
and increases the phosphorylation of key protein kinases (mTOR
and p70S6k phospho/total ratio) and the transcription factors
(FoxO3a phospho/total ratio) related to RE-induced muscle
remodeling. However, unexpectedly, Leu supplementation in
a dose known to increase muscle protein synthesis in healthy
rats worsened and decreased such beneﬁcial effects of RE. Future
studies should address the potential role of other RE protocols,
the dose–response effect of Leu supplementation, and the effect
of exercise in the death toll in such catabolic conditions.Acknowledgments
The authors are grateful to Prof. Dr. Deborah Schechtman.
Also, they thank Ajinomoto (Tokyo, Japan) for providing the
supplements.Supplementary data
Supplementary data related to this article can be found online
at doi:10.1016/j.nut.2011.08.008.References
[1] Nicastro H, Artioli GG, Costa Ados S, Solis MY, da Luz CR, Blachier F,
Lancha AH Jr. An overview of the therapeutic effects of leucine supple-
mentation on skeletal muscle under atrophic conditions. Amino Acids
2011;40:287–300.
[2] Zanchi NE, Nicastro H, Lancha AH Jr. Potential antiproteolytic effects of
L-leucine: observations of in vitro and in vivo studies. Nutr Metab (Lond)
2008;5:20.
[3] Baptista IL, Leal ML, Artioli GG, Aoki MS, Fiamoncini J, Turri AO, et al.
Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin
ligases. Muscle Nerve 2010;41:800–8.
[4] Marzani B, Balage M, Venien A, Astruc T, Papet I, Dardevet D, Mosoni L.
Antioxidant supplementation restores defective leucine stimulation of
protein synthesis in skeletal muscle from old rats. J Nutr 2008;138:
2205–11.
[5] Rieu I, Balage M, Sornet C, Debras E, Ripes S, Rochon-Bonhomme C,
Pouyet C, et al. Increased availability of leucine with leucine-rich whey
proteins improves postprandial muscle protein synthesis in aging rats.
Nutrition 2007;23:323–31.
[6] Combaret L, Dardevet D, Rieu I, Pouch MN, Bechet D, Taillandier D, et al.
A leucine-supplemented diet restores the defective postprandial inhibition
of proteasome-dependent proteolysis in aged rat skeletal muscle. J Physiol
2005;569:489–99.
H. Nicastro et al. / Nutrition 28 (2012) 465–471 471[7] De Bandt JP, Cynober L. Therapeutic use of branched-chain amino acids in
burn, trauma, and sepsis. J Nutr 2006;136:308S–13S.
[8] da Silva PM, Zoppi CC, Filiputti E, Silveira LR, Quesada I, Boschero AC,
Carneiro EM. Preliminary report: leucine supplementation enhances
glutamate dehydrogenase expression and restores glucose-induced insulin
secretion in protein-malnourished rats. Metabolism 2010;59:911–3.
[9] Filiputti E, Rafacho A, Araujo EP, Silveira LR, Trevisan A, Batista TM, et al.
Augmentation of insulin secretion by leucine supplementation in
malnourished rats: possible involvement of the phosphatidylinositol
3-phosphate kinase/mammalian target protein of rapamycin pathway.
Metabolism 2010;59:635–44.
[10] Little JP, Phillips SM. Resistance exercise and nutrition to counteract muscle
wasting. Appl Physiol Nutr Metab 2009;34:817–28.
[11] Phillips SM. Physiologic and molecular bases of muscle hypertrophy and
atrophy: impact of resistance exercise on human skeletal muscle (protein
and exercise dose effects). Appl Physiol Nutr Metab 2009;34:403–10.
[12] Linderman JK, Gosselink KL, Booth FW, Mukku VR, Grindeland RE. Resis-
tance exercise and growth hormone as countermeasures for skeletal
muscle atrophy in hindlimb-suspended rats. Am J Physiol Regul Integr
Comp Physiol 1994;267:R365–71.
[13] Adams GR, Haddad F, Bodell PW, Tran PD, Baldwin KM. Combined isometric,
concentric, and eccentric resistance exercise prevents unloading-induced
muscle atrophy in rats. J Appl Physiol 2007;103:1644–54.
[14] Haddad F, Adams GR, Bodell PW, Baldwin KM. Isometric resistance exercise
fails to counteract skeletal muscle atrophy processes during the initial
stages of unloading. J Appl Physiol 2006;100:433–41.
[15] Dupont-Versteegden EE, Fluckey JD, Knox M, Gaddy D, Peterson CA.
Effect of ﬂywheel-based resistance exercise on processes contributing to
muscle atrophy during unloading in adult rats. J Appl Physiol 2006;101:
202–12.
[16] Fluckey JD, Dupont-Versteegden EE, Montague DC, Knox M, Tesch P,
Peterson CA, Gaddy-Kurten D. A rat resistance exercise regimen attenuates
losses of musculoskeletal mass during hindlimb suspension. Acta Physiol
Scand 2002;176:293–300.
[17] Gualano B, Ugrinowitsch C, Neves M Jr, Lima FR, Pinto AL, Laurentino G,
et al. Vascular occlusion training for inclusion body myositis: a novel
therapeutic approach. J Vis Exp 2010;5:1894.
[18] Pereira LO, Lancha AH Jr. Effect of insulin and contraction up on glucose
transport in skeletal muscle. Prog Biophys Mol Biol 2004;84:1–27.
[19] Gualano B, de Salles Painneli V, Roschel H, Artioli GG, Junior MN, Lucia de
Sa Pinto A, et al. Creatine in type 2 diabetes: a randomized, double-blind,
placebo-controlled trial. Med Sci Sports Exerc 2011;43:770–8.
[20] Zanchi NE, Filho MA, Felitti V, Nicastro H, Lorenzeti FM, Lancha AH Jr.
Glucocorticoids: extensive physiological actions modulated through
multiple mechanisms of gene regulation. J Cell Physiol 2010;224:311–5.
[21] Bernal-Mizrachi C, Weng S, Feng C, Finck BN, Knutsen RH, Leone TC, et al.
Dexamethasone induction of hypertension and diabetes is PPAR-alpha
dependent in LDL receptor-null mice. Nat Med 2003;9:1069–75.
[22] Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ. Glucocorticoid regulation
of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat
skeletal muscle in vivo. J Clin Invest 1993;91:2020–30.
[23] Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, et al. The
E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-
treated skeletal muscle. Cell Metab 2007;6:376–85.
[24] Gilson H, Schakman O, Combaret L, Lause P, Grobet L, Attaix D, et al.
Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
Endocrinology 2007;148:452–60.
[25] Hasselgren PO. Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr
Metab Care 1999;2:201–5.
[26] Waddell DS, Baehr LM, van den Brandt J, Johnsen SA, Reichardt HM,
Furlow JD, Bodine SC. The glucocorticoid receptor and FOXO1 synergisti-
cally activate the skeletal muscle atrophy-associated MuRF1 gene. Am J
Physiol Endocrinol Metab 2008;295:E785–97.
[27] Falduto MT, Czerwinski SM, Hickson RC. Glucocorticoid-induced muscle
atrophy prevention by exercise in fast-twitch ﬁbers. J Appl Physiol 1990;
69:1058–62.
[28] Nicastro H, Gualano B, de Moraes WMAM, de Salles Painelli V, da Luz CR,
dos Santos Costa A, et al. Effects of creatine supplementation on musclewasting and glucose homeostasis in rats treated with high dose of dexa-
methasone. Amino Acids; 2011 (in press).
[29] Crozier SJ, Kimball SR, Emmert SW, Anthony JC, Jefferson LS. Oral leucine
administration stimulates protein synthesis in rat skeletal muscle. J Nutr
2005;135:376–82.
[30] Wirth O, Gregory EW, Cutlip RG, Miller GR. Control and quantitation of
voluntary weight-lifting performance of rats. J Appl Physiol 2003;95:402–12.
[31] Zanchi NE, Lira FS, Seelaender M, Lancha AH Jr. Experimental chronic low-
frequency resistance training produces skeletal muscle hypertrophy in the
absence of muscle damage and metabolic stress markers. Cell Biochem
Funct 2010;28:232–8.
[32] Zanchi NE, Lira FS, de Siqueira Filho MA, Rosa JC, de Oliveira Carvalho CR,
Seelaender M, et al. Chronic low frequency/low volume resistance training
reduces pro-inﬂammatory cytokine protein levels and TLR4 mRNA in rat
skeletal muscle. Eur J Appl Physiol 2010;109:1095–102.
[33] Lira FS, Koyama CH, Yamashita AS, Rosa JC, Zanchi NE, Batista ML Jr,
Seelaender MC. Chronic exercise decreases cytokine production in healthy
rat skeletal muscle. Cell Biochem Funct 2009;27:458–61.
[34] Fry AC. The role of resistance exercise intensity on muscle ﬁbre adapta-
tions. Sports Med 2004;34:663–79.
[35] Kauvar DS, Baer DG, Walters TJ. Inﬂuence of systemic hypotension on
skeletal muscle ischemia-reperfusion injury after 4-hour tourniquet
application. J Surg Educ 2007;64:273–7.
[36] Adami GF, Cordera R, Andraghetti G, Camerini GB, Marinari GM,
Scopinaro N. Changes in serum ghrelin concentration following bil-
iopancreatic diversion for obesity. Obes Res 2004;12:684–7.
[37] de Salles Painelli V, Gualano B, Artioli GG, de Sa Pinto AL, Bonfa E, Lancha
Junior AH, Lima FR. The possible role of physical exercise on the treatment
of idiopathic inﬂammatory myopathies. Autoimmun Rev 2009;8:355–9.
[38] Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, et al.
Acute exercise induces GLUT4 translocation in skeletal muscle of normal
human subjects and subjects with type 2 diabetes. Diabetes 1999;48:
1192–7.
[39] Thorell A, Hirshman MF, Nygren J, Jorfeldt L, Wojtaszewski JF, Dufresne SD,
et al. Exercise and insulin cause GLUT-4 translocation in human skeletal
muscle. Am J Physiol Endocrinol Metab 1999;277:E733–41.
[40] Terzis G, Spengos K, Mascher H, Georgiadis G, Manta P, Blomstrand E. The
degree of p70 S6k and S6 phosphorylation in human skeletal muscle in
response to resistance exercise depends on the training volume. Eur J Appl
Physiol 2010;110:835–43.
[41] Zanchi NE, Lancha AH Jr. Mechanical stimuli of skeletal muscle: implica-
tions on mTOR/p70s6k and protein synthesis. Eur J Appl Physiol
2008;102:253–63.
[42] Terzis G, Georgiadis G, Stratakos G, Vogiatzis I, Kavouras S, Manta P, et al.
Resistance exercise-induced increase in muscle mass correlates with p70S6
kinase phosphorylation in human subjects. Eur J Appl Physiol 2008;
102:145–52.
[43] Apro W, Blomstrand E. Inﬂuence of supplementation with branched-chain
amino acids in combination with resistance exercise on p70S6 kinase
phosphorylation in resting and exercising human skeletal muscle. Acta
Physiol (Oxf) 2010;200:237–48.
[44] Pellegrino MA, D’Antona G, Bortolotto S, Boschi F, Pastoris O, Bottinelli R,
et al. Clenbuterol antagonizes glucocorticoid-induced atrophy and ﬁbre
type transformation in mice. Exp Physiol 2004;89:89–100.
[45] Nicastro H, Artioli GG, Dos Santos Costa A, Solis MY, da Luz CR, Blachier F,
Lancha AH Jr. An overview of the therapeutic effects of leucine supple-
mentation on skeletal muscle under atrophic conditions. Amino Acids
2011;40:287–300.
[46] Rieu I, Balage M, Sornet C, Giraudet C, Pujos E, Grizard J, et al. Leucine
supplementation improves muscle protein synthesis in elderly men inde-
pendently of hyperaminoacidaemia. J Physiol 2006;575:305–15.
[47] Dardevet D, Rieu I, Fafournoux P, Sornet C, Combaret L, Bruhat A, et al.
Leucine: a key amino acid in ageing-associated sarcopenia? Nutr Res Rev
2003;16:61–70.
[48] Balage M, Dupont J, Mothe-Satney I, Tesseraud S, Mosoni L, Dardevet D.
Leucine supplementation in rats induced a delay in muscle IR/PI3K
signaling pathway associated with overall impaired glucose tolerance.
J Nutr Biochem 2010;22:219–26.
